MedTrace Logo

Preoperative Nerve Block for Rhinoplasty/Septoplasty

NCT03780478 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-07-30

No results posted yet for this study

Summary

Addiction is an inherent risk when prescribing opiates for pain relief, and methods to reduce its use or amount prescribed can help mitigate this risk for addiction. Patients undergoing rhinoplasty are often prescribed a short course of opiates during the acute post surgical phase. Studies have shown intraoperative sphenopalatine ganglion (SPG) nerve block in endoscopic sinus surgery can reduce post operative narcotic use. The purpose of this study is to determine if use of SPG block can be used to reduce narcotic use in the acute post operative phase of rhinoplasty/septoplasty.

Conditions

  • Nasal Fracture
  • Deviated Nasal Septum

Interventions

DRUG

Nerve block

0.25% bupivacaine with epinephrine (1:100k), with total volume of 2mL

DRUG

Placebo Saline Injection

Saline injection, total volume 2ml

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Amit Kochhar, MD · USC Keck Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2021-12-31
Completion
2022-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780478 on ClinicalTrials.gov